Biotech

All Articles

Kailera launches along with $400M series A, 4 Mandarin weight problems drugs

.Kailera Therapeutics has actually released into the significantly crowded being overweight space al...

Metsera coordinate with Amneal to latch down GLP-1 supply

.With early phase 1 information right now out in the wild, metabolic ailment clothing Metsera is was...

Rivus posts information to back up muscle-sparing obesity medication insurance claims

.Rivus Pharmaceuticals has revealed the data responsible for its own phase 2 weight problems win in ...

BMS spends $110M to form T-cell therapy deal, assisting Excellent purchase opportunity to develop prioritized pipe

.Bristol Myers Squibb is paying for Perfect Medicine $110 thousand upfront to cultivate reagents for...

Generate gains one more $1B-plus Big Pharma collaboration

.Novartis has inked an offer possibly worth more than $1 billion with Flagship-founded Generate: Bio...

Metsera GLP-1 information piece exposes 7.5% weight management at 36 times

.Lately debuted Metsera is actually unfolding some stage 1 information for its own GLP-1 receptor ag...

Flagship really hopes biotechs flock to Mirai to increase genetic meds

.Among the genetic medications arms race, Main Pioneering is actually introducing a brand-new busine...

BioAge eyes $180M coming from IPO, private positioning for being overweight tests

.BioAge Labs is actually considering about $180 thousand in first proceeds coming from an IPO and al...

Merck's LAG-3 combination fails colon cancer cells phase 3 study

.An effort through Merck &amp Co. to unlock the microsatellite steady (MSS) metastatic colon cancer ...

Spanish VC closes $200M life sciences fund

.Spain-based Asabys Partners has finalized a fund of 180 thousand euros ($ 200 million), amount of m...